Alyeska Investment Group, L.P. Merus N.V. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Merus N.V. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 136,364 shares of MRUS stock, worth $6.46 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
136,364Holding current value
$6.46 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
60.7MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$198 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$184 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$166 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$141 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$126 Million1.81% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.17B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...